BioSpace News Archive

Policy

Trevena Announces Submission of New Drug Application to FDA for OLINVO (oliceridine injection)

The filing is supported by positive Phase 3 APOLLO and ATHENA studies.

November 2, 2017
·
4 min read
Business

NAI Appoints Trilogy As New Sales Representative in Midwest

Effective immediately, Trilogy will represent NAI’s unique capabilities in the design and manufacturing of cable assemblies and harnesses.

November 2, 2017
·
3 min read
Business

Zealand Reports Royalty Revenue for the Third Quarter of 2017

Total royalty revenue for the first nine months of 2017 amounted to DKK 27.5 million/USD 4.4 million.

November 2, 2017
·
2 min read
Business

ReWalk Robotics Reports Third Quarter 2017 Financial Results

Revenues grew 24% to $1.7 million and 46% to $6.2 million for the three and nine months ended September 30, 2017, respectively.

November 2, 2017
·
12 min read
Policy

Photocure ASA: U.S. CMS Improves Reimbursement for Blue Light Cystoscopy With Cysview

The U.S. Centers for Medicare & Medicaid Services has issued a Final Rule stating that it will reimburse hospital outpatient departments for certain Blue Light Cystoscopy (BLC(TM)) with Cysview procedures from January 1, 2018.

November 2, 2017
·
4 min read
Business

Targovax ASA: Third Quarter 2017 Results

A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET.

November 2, 2017
·
4 min read
Business

MDxHealth Nine Month Trading Update

Total revenue of $30.5 million, up 38% from the same period in 2016, in part driven by $12.1 million net revenue from a one-time buy-out of the Company’s patents directed towards colorectal cancer to Exact Sciences.

November 2, 2017
·
9 min read
Business

DATATRAK Reports Third Quarter Results of 2017

DATATRAK reduced its direct costs by 15% and its SG&A expenses by 1% for the three months ended September 30, 2017 compared to the three months ended September 30, 2016.

November 2, 2017
·
14 min read
Business

Neos Therapeutics to Host Third Quarter 2017 Financial Results Conference Call on November 8, 2017

Management will host a conference call and live audio webcast to discuss these results and provide a company update at 8:30 a.m. ET that same day.

November 2, 2017
·
1 min read
Dr. Reddy’s Laboratories Announces the Launch of Generic Azacitidine for Injection in the Canadian Market

Dr. Reddy’s Laboratories is pleased to announce that generic Azacitidine for injection 100 mg/vial, a bioequivalent generic version of VIDAZA (azacitidine for injection), is approved by Health Canada.

November 2, 2017
·
3 min read